BENITIONSClinical Trial Intelligence

Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines

Фаза 4 Прекращено NCT02090998

ЗаболеваниеTransformed Migraine, Chronic Daily Headache
ФазаФаза 4
СпонсорRutgers, The State University of New Jersey
СтатусПрекращено
Участники10 участн.
ВмешательствоSPG Block with 5% Lidocaine gel, Amitriptyline
Дата начала05.2014
Дата завершения16.03.2020
Публикация результатов29.12.2021

Кратко

This study will compare a local anesthetic technique that has been used to treat subjects suffering from transformed migraines (chronic migraines) versus medical management with traditional antidepressant Amitriptyline / Elavil. Subjects will be randomized into one of two treatment groups to compare the safety and efficacy of the therapies. Subjects will recieve either sphenopalatine ganglion nerve block with 5% lidocaine gel into the nasopharynx or medical management with traditional antidepressants, Elavil, to produce a reduction in the frequency and severity of the headache. We propose that there will be a difference in the outcomes when comparing the two methods of treating transformed migraines and that one research arm will result in more patient satisfaction and greater efficacy in the treatment of subjects

Number of Daily Headaches

Study Day 1 through Study Day 30 · Number of Daily Headaches

Amitriptyline / Elavil20.5 ± 0.5 Number of Daily Headaches
SPG Nerve Block With Lidocaine 5% Gel13.4 ± 10.4 Number of Daily Headaches

Открыть в BENITIONS Открыть на ClinicalTrials.gov

Другие исследования по этому заболеванию

Все исследования

Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.